PL1869166T3 - Produkcja populacji komórek in vitro z zastosowaniem komórek odżywczych - Google Patents

Produkcja populacji komórek in vitro z zastosowaniem komórek odżywczych

Info

Publication number
PL1869166T3
PL1869166T3 PL06743329T PL06743329T PL1869166T3 PL 1869166 T3 PL1869166 T3 PL 1869166T3 PL 06743329 T PL06743329 T PL 06743329T PL 06743329 T PL06743329 T PL 06743329T PL 1869166 T3 PL1869166 T3 PL 1869166T3
Authority
PL
Poland
Prior art keywords
cell population
feeder cells
vitro production
vitro
production
Prior art date
Application number
PL06743329T
Other languages
English (en)
Inventor
Hervé Groux
Françoise Cottrez
Hervé Bastian
Valérie Brun
Original Assignee
Txcell
Inst Nat Sante Rech Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Txcell, Inst Nat Sante Rech Med filed Critical Txcell
Publication of PL1869166T3 publication Critical patent/PL1869166T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0634Cells from the blood or the immune system
    • C12N5/0636T lymphocytes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/90Serum-free medium, which may still contain naturally-sourced components
    • C12N2500/95Protein-free medium and culture conditions
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20Cytokines; Chemokines
    • C12N2501/23Interleukins [IL]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • C12N2501/51B7 molecules, e.g. CD80, CD86, CD28 (ligand), CD152 (ligand)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • C12N2501/515CD3, T-cell receptor complex
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50Cell markers; Cell surface determinants
    • C12N2501/53CD2
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/50Coculture with; Conditioned medium produced by invertebrate cells
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00Coculture with; Conditioned medium produced by
    • C12N2502/99Coculture with; Conditioned medium produced by genetically modified cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL06743329T 2005-04-15 2006-04-18 Produkcja populacji komórek in vitro z zastosowaniem komórek odżywczych PL1869166T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05290836A EP1712615A1 (en) 2005-04-15 2005-04-15 In vitro production of a cell population using feeder cells
PCT/EP2006/061648 WO2006108882A1 (en) 2005-04-15 2006-04-18 In vitro production of a cell population using feeder cells
EP06743329A EP1869166B1 (en) 2005-04-15 2006-04-18 In vitro production of a cell population using feeder cells

Publications (1)

Publication Number Publication Date
PL1869166T3 true PL1869166T3 (pl) 2012-12-31

Family

ID=34942139

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06743329T PL1869166T3 (pl) 2005-04-15 2006-04-18 Produkcja populacji komórek in vitro z zastosowaniem komórek odżywczych

Country Status (12)

Country Link
US (1) US8722401B2 (pl)
EP (2) EP1712615A1 (pl)
JP (2) JP5247431B2 (pl)
AU (1) AU2006234338B2 (pl)
CA (1) CA2604697A1 (pl)
CY (1) CY1113321T1 (pl)
DK (1) DK1869166T3 (pl)
ES (1) ES2389502T3 (pl)
PL (1) PL1869166T3 (pl)
PT (1) PT1869166E (pl)
SI (1) SI1869166T1 (pl)
WO (1) WO2006108882A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1712615A1 (en) * 2005-04-15 2006-10-18 Txcell In vitro production of a cell population using feeder cells
DK1739166T3 (da) * 2005-07-01 2011-10-10 Txcell S A Fremstilling af fødevare- eller autoantigen-specifikke Tr1-celler fra en leukocyt- eller PBMC-population
EP2050814A1 (en) 2007-10-17 2009-04-22 Txcell Compositions for treating multiple sclerosis
EP2062970A1 (en) * 2007-11-26 2009-05-27 Txcell Compositions for treating an intestinal inflammatory condition
PL2113254T3 (pl) 2008-04-28 2013-01-31 Txcell Kompozycje do leczenia autoimmunologicznego stanu zapalnego
EP2113560A1 (en) 2008-04-28 2009-11-04 TXCell Compositions for treating an arthritic condition
US20120149598A1 (en) * 2009-01-23 2012-06-14 Tomoyuki Inoue Feeder cells for target cell induction
EP2221364A1 (en) 2009-02-23 2010-08-25 TXCell Compositions for treating an allergic or asthmatic condition
EP2378287A1 (en) * 2010-04-15 2011-10-19 TXCell New method for isolating Tr1 cells
EP2412802A1 (en) 2010-07-29 2012-02-01 TXCell IL-13 producing TR1-like cells and use thereof
EP2689009A1 (en) * 2011-03-25 2014-01-29 TXCell Method for using regulatory t cells in therapy
GB201121308D0 (en) 2011-12-12 2012-01-25 Cell Medica Ltd Process
KR101749195B1 (ko) 2011-12-12 2017-06-20 셀 메디카 리미티드 T 세포들을 증식시키는 방법
HRP20221303T1 (hr) 2012-02-09 2022-12-23 Baylor College Of Medicine SMJESE PEPTIDA ZA NASTAJANJE MULTIVIRUSNIH CITOTOKSIČNIH T-LIMFOCITA(CTLs) ŠIROKE SPECIFIČNOSTI
EP2982746A1 (en) 2014-08-07 2016-02-10 TXCell Regulatory T cells with therapeutic potential
IL298359A (en) 2015-09-18 2023-01-01 Baylor College Medicine Immunogenic detection of antigen from a pathogen and adjustment of effective clinical treatment
WO2019217512A1 (en) * 2018-05-08 2019-11-14 Life Technologies Corporation Compositions and methods for culturing and expanding cells

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6352694B1 (en) * 1994-06-03 2002-03-05 Genetics Institute, Inc. Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells
JP3926842B2 (ja) * 1995-03-08 2007-06-06 ザ・スクリプス・リサーチ・インステイチユート 抗原提示系およびt−細胞の活性化方法
WO1997046256A1 (en) * 1996-05-23 1997-12-11 The Scripps Research Institute Mhc class ii antigen-presenting systems and methods for activating cd4+ t cells
FR2824567B1 (fr) * 2001-05-11 2003-08-08 Inst Nat Sante Rech Med Procede d'obtention de lymphocytes tr1 regulateurs specifiques d'antigene
US20040173778A1 (en) * 2001-05-30 2004-09-09 Roncarolo Maria Grazia Ex-vivo isolated cd25+cd4+ t cells with immunosuppressive activity and uses thereof
WO2003057171A2 (en) 2002-01-03 2003-07-17 The Trustees Of The University Of Pennsylvania Activation and expansion of t-cells using an engineered multivalent signaling platform
FR2856700B1 (fr) 2003-06-24 2007-06-08 Txcell Procede d'identification de lymphocytes tr1 regulateurs par la presence et la surexpression de molecules specifiques et ses applications
US20050048578A1 (en) * 2003-06-26 2005-03-03 Epitomics, Inc. Methods of screening for monoclonal antibodies with desirable activity
US7754482B2 (en) * 2004-05-27 2010-07-13 The Trustees Of The University Of Pennsylvania Artificial antigen presenting cells and uses therefor
EP1712615A1 (en) * 2005-04-15 2006-10-18 Txcell In vitro production of a cell population using feeder cells

Also Published As

Publication number Publication date
PT1869166E (pt) 2012-09-18
JP5247431B2 (ja) 2013-07-24
EP1712615A1 (en) 2006-10-18
CA2604697A1 (en) 2006-10-19
JP2008535525A (ja) 2008-09-04
WO2006108882A8 (en) 2006-12-14
WO2006108882A1 (en) 2006-10-19
US20090221070A1 (en) 2009-09-03
DK1869166T3 (da) 2012-09-24
US8722401B2 (en) 2014-05-13
JP2013116105A (ja) 2013-06-13
ES2389502T3 (es) 2012-10-26
EP1869166B1 (en) 2012-06-13
EP1869166A1 (en) 2007-12-26
CY1113321T1 (el) 2016-04-13
AU2006234338A1 (en) 2006-10-19
AU2006234338B2 (en) 2011-09-15
SI1869166T1 (sl) 2012-11-30

Similar Documents

Publication Publication Date Title
SI1869166T1 (sl) In vitro produkcija populacije celic z uporabo hranilnih celic
EP2584034B8 (en) Pluripotent stem cell differentiation by using human feeder cells
IL187352A0 (en) Establishment of a human embryonic stem cell line using mammalian cells
GB0605450D0 (en) Cell co-culture
HK1130509A1 (en) Method for production of t cell population t
GB0519599D0 (en) Photovoltaic cells
IL197444A0 (en) Cell culture improvements
EP2093824A4 (en) FIXED ELECTROLYTE STRUCTURE FOR A THRESHOLD SOLID BODY BATTERY, THRESHOLD FIXED BODY BATTERY AND MANUFACTURING METHOD THEREFOR
EP1882736A4 (en) RECIPIENT CELL CULTURE
EP1902476A4 (en) METHODS OF ENERGY TRANSFER BY PHOTOVOLTAIC CELLS
HK1112483A1 (zh) 體外製備腫瘤細胞以激活自然殺傷細胞的方法
GB0525579D0 (en) Cell culture vessel
EP1734605A4 (en) FERTELECTROLYTTYF FUEL CELL
GB2429211B (en) Feeder independent extended culture of embryonic stem cells
GB0517382D0 (en) Cell culture
EP1969666A4 (en) STACK AND SUPPORT FOR ELECTROCHEMICAL CELLS
EP1967582A4 (en) MATERIAL FOR CELL CULTURE
EP1870942A4 (en) SOLAR CELL
EP1947722A4 (en) FUEL CELLS AND PROCESS FOR THE MANUFACTURE OF THEIR SEPARATORS
EP1898468A4 (en) SOLAR BATTERY CELL
EP1859027A4 (en) IMMORTALIZED NOURISH CELLS
EP1997884A4 (en) NEW HUMAN T-CELL POPULATION
ZA200804743B (en) Photovoltaic cell
HK1106558A1 (en) Electrochemical cell
EP2019860A4 (en) PROTEIN PRODUCTION USING EUKARYOTIC CELL LINES